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ABSTRACT: Endotoxin is the major structural constituent of the outer
membrane of Gram-negative bacteria, which is a great threat to human
health. Herein, a sensitive electrochemical biosensor for the detection of
endotoxin is established by recording the voltammetric responses of the
peptide-modiﬁed electrode. The utilized peptide has a high aﬃnity for the
target endotoxin, which ensures the high selectivity of this method. After
the capture of endotoxin on the electrode surface, a negatively charged
layer is formed, and the electron-transfer process is signiﬁcantly hindered because of the increased steric hindrance and the
electrostatic repulsion. The declined electrochemical signal could be used to indicate the concentration of endotoxin. This
method is simple but eﬀective, which requires limited reagents. Another highlight of this method is its user-friendly operation.
Moreover, its applicability in human blood plasma promises its great potential utility in the near future.

■

INTRODUCTION
Endotoxin, commonly termed as lipopolysaccharide (LPS), is
the major structural constituent of the outer membrane of
Gram-negative bacteria.1,2 It comprises polysaccharide and lipid
A (Scheme 1a). Lipid A moiety is of high toxicity to human
beings with pyrogenic property,3 and endotoxin is highly
responsible for the incidence of a diversity of human diseases
such as asthma, coughing, fever, vomiting, dyspnea, diarrhea,
shock, and so on.4,5 Because endotoxin can be easily released
into the bloodstream during the growth of bacterial cells and
cause severe human disorders, it is urgent to detect such healththreatening toxin in foodstuﬀ and medical supplies.6−9
Limulus amebocyte lysate (LAL) tests are commonly used
for endotoxin quantiﬁcation with three main strategies
including the gel-clot method,10 the turbidimetric method,11
and the chromogenic method.12 LAL reagents are an aqueous
extract of blood cells produced from the horseshoe crab. After
the reaction with endotoxin, obvious signals are generated,
which is due to the concentration of endotoxin. To achieve
higher sensitivities, more LAL reagent-based assays have been
developed such as elastography method,13 quartz crystal
microbalance sensor,14 and electrochemical sensor.15 However,
all of these endotoxin detection methods rely on LAL reagents,
which have many disadvantages including false aﬃrmative
responses and limited horseshoe crab sources.16
So far, signiﬁcant eﬀorts have been directed toward the
development of LAL reagent-free analytical methods. For
instance, aptamer is a speciﬁc single-stranded DNA that
interacts with diﬀerent targets having certain nanostructures.17,18 Su et al. made use of aptamers as the recognition
© 2017 American Chemical Society

element, which showed high aﬃnity for endotoxin in the
fabrication of an impedance biosensor.19 Paul et al. employed
cetyltrimethylammonium bromide-capped gold nanospheres
for ﬂuorimetric sensing of endotoxin, utilizing the electrostatic
interaction between nanomaterials and endotoxin that might
enhance the ﬂuorescence intensity.20 Nieradka et al. developed
a microcantilever array biosensor for the sensitive detection of
endotoxin with the help of a monoclonal antibody.21 Ding et al.
prepared polymyxin B-immobilized gold electrodes to recognize and detect endotoxin using electrochemical impedance
spectroscopy (EIS).22 Jiang et al. designed living cells to probe
endotoxin, which could activate the expression of ﬂuorescent
protein, and an optical biosensor was thus established.23
Besides, peptides can also be used as an alternative
recognition element.24 Endotoxin-binding peptides have been
exploited recently.25 The peptides can not only neutralize the
toxicity of endotoxin, blocking the induced inﬂammatory
responses for sepsis treatment,26 but also have the potential
to be used as speciﬁc ligands to develop various fast and reliable
detection methods for endotoxin.27 Phage display is the
standard technique for screening speciﬁc binding peptides to
target molecules. The phage display library contains diﬀerent
phage clones that encode diﬀerent peptides or proteins.28 In
2005, Kim et al. selected two peptides, AWLPWAK and
NLQEFLF, by biopanning on endotoxin-conjugated epoxy
beads. The two peptides were found to interact with the
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ential pulse voltammetry (DPV) responses, the endotoxin
concentration could be quantitatively determined.

Scheme 1. (a) Structure of Endotoxin. Reproduced from
Kalita, P.; Dasgupta, A.; Sritharan, V.; Gupta, S. Anal. Chem.
2015, 87, 11007−11012 (Ref 2). Copyright 2015 American
Chemical Society. (b) Illustration of the Peptide-Based
Electrochemical Approach for the Detection of Endotoxin

■

RESULTS AND DISCUSSION
EIS is ﬁrst used for the characterization of the modiﬁed
electrode in diﬀerent steps using the redox probe of
Fe(CN)63−/4−. In a typical Nyquist plot, the semicircle portion
observed at higher frequencies is related to the electrontransfer-limiting process, and the linear portion at lower
frequencies is related to the diﬀusion process. As shown in
Figure 1, when the electrode was modiﬁed with the peptide and

Figure 1. Nyquist plots corresponding to (a) bare gold electrode, (b)
peptide-modiﬁed electrode, and (c) after interacting with endotoxin
(10 EU/mL).

then MCH, a small semicircle appears, whereas a straight line is
exhibited in the case of bare electrode. After the capture of a
negatively charged endotoxin, the electron-transfer resistance
increases owing to the steric hindrance and electrostatic
repulsive force to Fe(CN)63−/4− anions, which can be reﬂected
by the signiﬁcantly enlarged semicircle portion. From the EIS
curves, molecular assembly events are well-conﬁrmed.
DPV is then employed to investigate the diﬀerent stages of
the electrode modiﬁcation. As shown in Figure 2, a large
current peak of Fe(CN)63−/4− is observed at bare electrode,
indicating an excellent electron-transfer eﬃciency. With the
immobilization of peptide and MCH, the peak decreases
slightly because of the balance of steric hindrance and
electrostatic attraction force to the electrochemical species. In
the next step, endotoxin is specially attached on the electrode
surface via the interaction between the peptide and endotoxin.
There has been a notable decrease in the peak current because
of the combined eﬀects of steric hindrance and electrostatic
repulsive force. These results conﬁrm the successful immobilization of diﬀerent molecules on the electrode surface during
the experimental procedures.
The performance of this electrochemical biosensor for the
endotoxin assay at diﬀerent concentrations and its repeatability
are evaluated. For selective capture, peptide with high aﬃnity is
chosen as the recognition element, and the DPV peak current is
used to indicate the level of endotoxin. Figure 3 shows the DPV
spectra of the electrochemical biosensor incubated with
diﬀerent amounts of endotoxin: 0, 0.1, 0.5, 2, 10, and 50
EU/mL (from bottom to top). The calibration plot of the peak
current versus the concentration of endotoxin is depicted in

polysaccharide moiety of endotoxin,29 which could be used for
the detection of Gram-negative bacteria.30 Guo and Chen then
implemented several modiﬁcations to regular phage display
procedure and selected another two peptides, ASFPPAF and
SSHTISF, with improved binding aﬃnity.31 Later, Matsumoto
et al. obtained the peptide named Li5-001 (KNYSSSISSIHAC),
which showed a high binding capacity to endotoxin with the Kd
value of 10 nM.32 They also tried to modify the sequence of
Li5-001 by replacing and deleting amino acids, and they found
that the obtained peptide Li5-017 (KNYSSSISSIHC) had a
higher endotoxin binding aﬃnity.33
In this article, we have referenced the peptide with a high
binding aﬃnity and developed an electrochemical method for
the detection of endotoxin in complex biological samples. The
working principle of the detection method is illustrated in
Scheme 1b. Gold electrode is used as the working electrode.
The peptide is ﬁrst immobilized onto the electrode surface
through the chemical adsorption of the C-terminal cysteine
residue.34 A positively charged interface derived from the other
residues is thus formed after the treatment with mercaptohexanol (MCH). A negatively charged electrochemical species,
Fe(CN)63−/4−, can easily get across to the electrode and
generate electrochemical signals. However, after the speciﬁc
interaction between the peptide and endotoxin, the electrontransfer process is signiﬁcantly hindered because of the
increased steric hindrance and the abundant negative charges
of endotoxin that repel Fe(CN)63−/4−. By comparing diﬀer2470
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Figure 4. Calibration curve representing the relationship between the
DPV peak current and the logarithmic endotoxin concentration (the
error bars display standard deviations of three independent measurements).

Figure 2. DPV curves corresponding to (a) bare gold electrode, (b)
peptide-modiﬁed electrode, and (c) after interacting with endotoxin
(10 EU/mL).

Table 1. Comparison between the Proposed Method and
Other Reported Sensors for Endotoxin Detection
technique
DPV
pyrogen
amperometry
EIS
magnetoelastic
sensor
ELISA
turbidimetry

Figure 3. DPV curves of the peptide-modiﬁed electrode after
interacting with diﬀerent amounts of endotoxin (0, 0.1, 0.5, 2, 10,
and 50 EU/mL, from bottom to top).

colorimetry
colorimetry
DPV

Figure 4 with the equation y = −8.740 + 3.923x (R2 = 0.994, n
= 3), in which y is the DPV peak current and x is the
logarithmic endotoxin concentration.
As shown in the plot (Figure 4), the peak current is
proportional to the endotoxin level over the range 0.1−50 EU/
mL, and the limit of detection is calculated to be 0.04 EU/mL
at 3σ based on the standard deviation of the blank signal (n =
3). The comparison results of the analytical performances of
the developed biosensor with some other reported methods are
given in Table 1. The limit of detection is among the lowest,
and the linear range is quite wide. Moreover, after being stored
at 4 °C for 1 month, the peptide-modiﬁed electrode will still be
suitable for accurate detection of endotoxin, which demonstrates the high stability of the proposed electrochemical
biosensor.
Attempts are further made to evaluate the analytical features
in real samples by employing Dulbecco’s modiﬁed Eagle’s
medium (DMEM) and human blood plasma samples for
endotoxin tests. The samples are ﬁrst spiked with diﬀerent
amounts of endotoxin (2, 4, and 8 EU/mL), which are then
used to interact with the peptide-modiﬁed electrode. DPV

limit of
detection
(EU/mL)

mechanism

ref/kit

Boc-Val-Pro-Arg-pnitroanilide
hydrolyzation
rabbit pyrogen test
competitive assay
endotoxin-neutralizing
protein
viscosity change of LAL

1

35

0.5
0.07
0.03

36
37
38

0.0105

39

end point ﬂuorescent
microplate assay
kinetic turbidimetric
LAL assay
end point chromogenic
LAL assay
end point chromogenic
LAL assay
peptide-based
recognition

0.05

EndoLISA

0.01

0.05

Lonza
BioScience
Thermo
Scientiﬁc
Sigma

0.04

this work

0.1

spectra are recorded. After comparing the peak current with the
established standard curve, the endotoxin concentrations are
calculated, which are listed in Table 2. The recoveries are
among 97.5 and 103.5%. The relative errors are smaller than
5.6%, demonstrating excellent repeatability and accuracy in real
Table 2. Results of Endotoxin Determination in Real
Samples
samples
DMEM

blood
plasma

2471

spiked
(EU/mL)

amount recovered
(EU/mL)

recovery
(%)

relative
error (%)

±
±
±
±

2
4
8
2

1.95
4.14
7.90
2.07

2.7
4.3
4.6
2.1

97.5
103.5
98.8
103.5

5.53
4.15
2.33
4.06

4
8

4.12 ± 4.2
8.13 ± 4.8

103.0
101.6

4.08
2.36
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N′-ethanesulfonic acid (HEPES) (20, 10 mM TCEP, and pH
6.0). The pretreated electrode was immersed in the above
peptide solution for 12 h at room temperature followed by the
treatment of 0.1 M MCH for 0.5 h, which could help the
formation of a well-aligned peptide monolayer. Subsequently,
the electrode was rinsed using 0.2 M NaOH prepared with 95%
ethanol to remove any absorbed endotoxin.
Endotoxin Analysis. Standard endotoxin was dissolved
using endotoxin-free water and swirled for 1 min. Then, it was
diluted to a series of concentrations. A 50 μL of standard
endotoxin was mixed with 50 μL of buﬀer solution (20 mM
Tris-HCl, 150 mM NaCl, and pH 7.5), which was then dipped
onto the surface of the peptide-modiﬁed gold electrode. After 1
h, buﬀer solution (20 mM Tris-HCl, 150 mM NaCl, 0.1%
Tween-20, and pH 7.5) was used to rinse the electrode. After
being dried with N2, DPV was conducted.
Real Sample Assay. DMEM and human blood plasma
were used as real samples. DMEM was diluted four times.
Human blood sample was collected using a dedicated
anticoagulation collection tube, which was then centrifuged at
3000g for 1 min. The obtained blood plasma was diluted 10
times using the buﬀer (50 mM Tris-HCl and pH 7.5), which
was then heated to 70 °C for 10 min. After cooling to room
temperature, the diluted DMEM and blood plasma were spiked
with diﬀerent amounts of endotoxin. Subsequently, the samples
were detected using the proposed electrochemical method.

samples. All of these results promise great potential practical
applications.

■

CONCLUSIONS
In summary, we have presented herein a simple and costeﬀective electrochemical approach for endotoxin biosensing.
Proof-of-concept DPV experiments reveal that endotoxin levels
could be readily distinguished. The dynamic range of the
method is from 0.1 to 50 EU/mL with a limit of detection as
low as 0.04 EU/mL. Because the chosen peptide has high
aﬃnity for endotoxin, interference can be inhibited, and this
method is suitable for endotoxin detection in real biological
samples, which has been proved by the experimental results.
This developed endotoxin biosensor may have potential
applications in testing the cell culture medium, pharmaceutical
products, and bacterial contaminations in drinking water and
environmental water.

■

EXPERIMENTAL SECTION
Materials and Chemicals. LAL reagents, standard
endotoxin, endotoxin-free pipet tips, and water were purchased
from Chinese Horseshoe Crab Reagent Manufactory Co., Ltd.
(Xiamen, China). Bovine serum albumin (BSA), glucose, 1-3-βD -glucan, tris(2-carboxyethyl)phosphine hydrochloride
(TCEP), MCH, and ethylenediaminetetraacetic acid were
purchased from Sigma-Aldrich (USA). MgCl2 and CaCl2
were purchased from Sinopharm Chemical Reagent Co, Ltd.
(China). Immunoglobulin G was obtained from Sino Biological
Inc. (China). DMEM was obtained from Gibco (Gaithersburg,
USA). Peptide (K-Li5) with the sequence of KKNYSSSISSIHC
was synthesized and puriﬁed by China Peptides Co., Ltd.
(Shanghai, China). Human blood samples were obtained from
healthy volunteers in the local hospital (Suzhou, China). The
other chemicals or reagents were of analytical grade as received.
Instrumentation. Electrochemical experiments were carried out on a CHI 660D electrochemical workstation (CH
instruments, China). A traditional three-electrode system was
employed, which consisted of an Ag/AgCl reference electrode,
a platinum wire counter electrode, and a modiﬁed gold working
electrode (2 mm diameter). EIS was performed in 5 mM
Fe(CN)63−/4− with 1 M KCl with the following parameters:
bias potential, 0.232 V; amplitude, 5 mV; frequency range, 0.1−
100 000 Hz. DPV was carried out in 5 mM Fe(CN)63−/4− with
1 M KCl. Parameters were as follows: initial potential, −0.4 V;
ﬁnal potential, 0.6 V; potential increment, 5 mV; amplitude, 50
mV; pulse width, 200 ms; and pulse period, 500 ms.
Electrode Pretreatment and Peptide Modiﬁcation.
Before the peptide modiﬁcation, the substrate gold electrode
was cleaned according to a previously reported literature.40
Brieﬂy, the electrode was ﬁrst immersed in piranha solution
(98% H2SO4:30% H2O2 = 3:1) for about 5 min (Caution:
Piranha solution reacts violently with organic solvents and
should be handled with great care!). Next, the electrode was
polished on P5000 sandpaper and then 1, 0.3, and 0.05 μm
alumina slurry. After that, it was rinsed with pure water and
then incubated in ethanol and pure water during ultrasonication
for 5 min, respectively. Afterward, the electrode was soaked in
50% HNO3 for 30 min and then electrochemically cleaned in
0.5 M H2SO4. Subsequently, it was rinsed with pure water and
dried with N2. To modify the peptide on the gold electrode
surface, the peptide (K-Li5) was ﬁrst dissolved in DMSO and
was diluted to be 0.2 mM with N-(2-hydroxyethyl)piperazine-
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